Condensed Consolidated Statements Of Operations - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues	$ 0	$ 0
Operating expenses:
Research and development	71,237,000	62,154,000
Selling, general and administrative	80,800,000	16,182,000
Total operating expenses	152,037,000	78,336,000
Loss from operations	(152,037,000)	(78,336,000)
Interest income	8,334,000	3,776,000
Interest expense	(3,838,000)	(2,336,000)
Net loss	$ (147,541,000)	$ (76,896,000)
Net loss per common share:
Basic net loss per common share (in dollars per share)	$ (7.38)	$ (4.23)
Diluted net loss per common share (in dollars per share)	$ (7.38)	$ (4.23)
Basic weighted average number of common shares outstanding (in shares)	20,001,569	18,187,924
Diluted weighted average number of common shares outstanding (in shares)	20,001,569	18,187,924